eClinical Solutions Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21622

Download Sample Report download
Buy the Full ReportStarting from $3999
Published on

January 2022

Total pages

254

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3999

About the Report

About the Report

eClinical platform vendors bundle applications and services into a single, integrated solution for running clinical trials. Life science CIOs are seeking to improve trial speed, quality and resource use should use this research as a planning for e-clinical platform adoption.

eClinical platforms reduce IT infrastructure costs, let companies manage the burgeoning stream of data from both sites and mobile devices, maintain compliance with changing safety regulations, and incorporate the technologies clinical researchers and sponsors need, more quickly and easily. This increased speed, flexibility and cost reduction is vital to meeting new expectations in clinical development. Additionally, a SaaS-based, eClinical platform enables the industry to address today's clinical needs, while being ready to adapt to new developments and innovation.

Based on Product, the eClinical solutions market is segmented into CDMS/EDC Solutions, CTMS Solutions, eCOA Solutions, RTMS Solutions, Safety Solutions, Analytics and Reporting Platforms, Integration Platforms, eTMF, and Others. Amongst Product, the CTMS Solutions segment of the market was valued at USD XX billion in 2020 and is likely to reach USD XX billion by 2027 growing at a CAGR of XX% from 2021-2027. CTMS is the clinical trial management system, which is the essential set of tools to effectively plan, manage and track your clinical study portfolio.

Based on Delivery Mode, the eClinical Solutions Market is segmented into Web-based (on-demand) Model, Licensed enterprise (on-premise) Model, and Cloud-based (SAAS) Model. Cloud Based (SAAS) Model segment accounted for a market valuation of USD XX billion in 2020 and is expected to reach USD XX billion by the year 2027, at a CAGR of XX% over the analyzed period. In 2018, technology giant Oracle launched a new holistic, unified cloud-based eClinical solution which was intended to bring new drugs to the market in a timely manner, while maintaining quality and safety.

Based on Clinical Trial Phase, the eClinical Solutions Market is segmented into Phase I, Phase II, Phase III, and Phase IV. Amongst Clinical Trial Phase, the Phase III segment of the market was valued at USD XX billion in 2020 and is likely to reach USD XX billion by 2027 growing at a CAGR of XX% from 2021-2027. The need for clinical data management software to curb overall cost and improve process efficiency is contributing to the growth of the segment.

Based on End-User, the eClinical Solutions Market is segmented into Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, and Academic Research Institutions. Amongst End- User, the Contract Research Organizations segment of the market was valued at USD XX billion in 2020 and is likely to reach USD XX billion by 2027 growing at a CAGR of XX% from 2021-2027. According to Research a 7.4% compound annual growth rate is predicted for the CRO market through 2019 and a market penetration rate of 72% by 2020.

For a better understanding of the market adoption of eClinical Solutions Industry, the market is analyzed based on its presence in the regions such as North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), Rest of World. North America will dominate the eClinical Solutions market on account of increasing popularity of chronic diseases.

Some of the major players operating in the market include Oracle Corporation, Medidata Solutions, Inc., Parexel International Corporation, BioClinica, Inc., Signant Health, Datatrak International, Inc., ERT, eClinical Solutions, Inc., MaxisIT Inc., and Bio-Optronics, Inc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

eClinical Solutions Market was valued at USD 7.2 billion in 2020 and is projected to expand significantly with a CAGR of 14% from 2021-2027F to USD 17 billion in 2027. The eClinical Solutions Market is expected to witness a boost on account of its high adoption in the North America region.

Products


Companies

Oracle Corporation, Medidata Solutions, Inc., Parexel International Corporation, BioClinica, Inc., Signant Health, Datatrak International, Inc., ERT, eClinical Solutions, Inc., MaxisIT Inc., and Bio-Optronics, Inc.

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Limitation

1.3. Stake Holders

1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the eClinical Solutions Market

2.2. Research Methodology of the eClinical Solutions Market

2.3. Forecasting Method

2.4. Respondent Profile

2.5. Main Objective of the eClinical Solutions Market Study

3 MARKET SYNOPSIS (INDUSTRY AT A GLANCE)

4 EXECUTIVE SUMMARY

5 eCLINICAL SOLUTIONS MARKET COVID-19 IMPACT

6 eCLINICAL SOLUTIONS MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

7.1. CDMS/EDC Solutions

7.2. CTMS Solutions

7.3. eCOA Solutions

7.4. RTMS Solutions

7.5. Safety Solutions

7.6. Analytics and Reporting Platforms

7.7. Integration Platforms

7.8. eTMF

7.9. Others

8 MARKET INSIGHTS BY DELIVERY MODE

8.1. Web-based (on-demand) Model

8.2. Licensed enterprise (on-premise) Model

8.3. Cloud-based (saas) Model

9 MARKET INSIGHTS BY CLINICAL TRIAL PHASE

9.1. Phase I

9.2. Phase II

9.3. Phase III

9.4. Phase IV

10 MARKET INSIGHTS BY END-USER

10.1. Pharmaceutical and Biopharmaceutical Companies

10.2. Contract Research Organizations

10.3. Consulting Service Companies

10.4. Medical Device Manufacturers

10.5. Hospitals

10.6. Academic Research Institutions

11 MARKET INSIGHTS BY REGION

11.1. NORTH AMERICA eCLINICAL SOLUTIONS

11.1.1. United States

11.1.2. Canada

11.1.3. Rest of North America

11.2. EUROPE eCLINICAL SOLUTIONS

11.2.1. Germany

11.2.2. United Kingdom

11.2.3. France

11.2.4. Spain

11.2.5. Italy

11.2.6. Rest of Europe

11.3. ASIA-PACIFIC eCLINICAL SOLUTIONS

11.3.1. China

11.3.2. Japan

11.3.3. India

11.3.4. Aurstralia

11.3.5. Rest of Asia-Pacific

11.4. REST OF THE WORLD eCLINICAL SOLUTIONS

12 eCLINICAL SOLUTIONS MARKET DYNAMICS

12.1. Drivers

12.2. Challenges

12.3. Impact Analysis

13 eCLINICAL SOLUTIONS MARKET OPPORTUNITIES

14 eCLINICAL SOLUTIONS MARKET TRENDS

15 LEGAL AND REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

16.1. Demand Side Analysis

16.2. Supply Side Analysis

16.2.1. Top Product Launches

16.2.2. Top Business Partnerships

16.2.3. Top Business Expansions, Investments and Divestitures

16.2.4. Top Merger and Acquisitions

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

18.1. Competitive Landscape

18.1.1. Company Shares, By Revenue

19 COMPANY PROFILED

19.1. Oracle Corporation

19.2. Medidata Solutions, Inc.

19.3. Parexel International Corporation

19.4. BioClinica, Inc.

19.5. Signant Health

19.6. Datatrak International, Inc.

19.7. ERT

19.8. eClinical Solutions, Inc.

19.9. MaxisIT Inc.

19.10. Bio-Optronics, Inc.

20 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022